Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban Wolfgang MueckJan StampfussMichael Becka Review Article Open access 03 September 2013 Pages: 1 - 16
Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2 Sreeneeranj KasichayanulaXiaoni LiuDavid W. Boulton Review Article 09 October 2013 Pages: 17 - 27
Pharmacokinetic of Antiepileptic Drugs in Patients with Hepatic or Renal Impairment Gail D. AndersonShahin Hakimian Review Article 13 October 2013 Pages: 29 - 49
Evaluation and Optimisation of Current Milrinone Prescribing for the Treatment and Prevention of Low Cardiac Output Syndrome in Paediatric Patients After Open Heart Surgery Using a Physiology-Based Pharmacokinetic Drug–Disease Model Winnie Vogt Original Research Article 10 July 2013 Pages: 51 - 72
A Mechanistic Framework for In Vitro–In Vivo Extrapolation of Liver Membrane Transporters: Prediction of Drug–Drug Interaction Between Rosuvastatin and Cyclosporine M. JameiF. BajotK. Rowland-Yeo Original Research Article Open access 24 July 2013 Pages: 73 - 87
Development of a Paediatric Population-Based Model of the Pharmacokinetics of Rivaroxaban Stefan WillmannCorina BeckerWolfgang Mück Original Research Article Open access 03 August 2013 Pages: 89 - 102
The Effect of St John’s Wort on the Pharmacokinetics of Docetaxel Andrew K. L. GoeyIrma MeijermanJan H. M. Schellens Original Research Article 26 September 2013 Pages: 103 - 110